FIELD: pharmaceutical industry. SUBSTANCE: method consists in spraying, onto carbamazepine, aqueous solution and/or dispersion of film former combined with softener in fluidized-bed granulator. Film forming agents are preferably mixtures of polyacrylates, for example, polyethylene acrylate and polymethylmethacrylate at weight ratio 2:1. Softener is preferably glycerin triacetate or triethyl citrate. Coated carbamazepine may be mixed with other auxiliary substances and compacted into divisible tablets or packaged into capsules. Method prevents growth of crystals associated with formation of carbamazepine dihydrate in presence of water. In consequence, release of carbamazepine is retarded and preparation of divisible tablets enabled. EFFECT: expanded possibilities of carbamazepine dosage. 9 cl, 2 dwg, 3 ex
Title | Year | Author | Number |
---|---|---|---|
CARBAMAZEPIN-BASE DRUG | 2001 |
|
RU2189225C1 |
PHARMACEUTICAL COMPOSITION ELICITING ANTICONVULSANT AND PSYCHOTROPIC EFFECT AND METHOD FOR ITS PREPARING | 2003 |
|
RU2240798C1 |
PHARMACEUTICAL COMPOSITION WITH ANTICONVULSIVE AND PSYCHOTROPIC ACTION | 2007 |
|
RU2342144C1 |
USE OF SELEGILINE FOR TREATMENT OF PATIENTS WITH EPILEPTIC DISEASE | 1995 |
|
RU2155584C2 |
METHOD OF PREPARING 5H-DIBENZ (b,f) AZEPIN-5-CARBOXAMIDE | 1994 |
|
RU2124504C1 |
MEDICINAL COMPOSITION CONTAINING FLUPIRTIN, WITH CONTROLLABLE RELEASE OF BIOLOGICALLY ACTIVE SUBSTANCE | 2006 |
|
RU2352338C2 |
PHARMACEUTICAL COMPOSITION OF OMEPRAZOL | 2012 |
|
RU2647472C2 |
NEW CONTROLLED-RELEASE GRANULES AND PHARMACEUTICAL PREPARATIONS CONTAINING SUCH GRANULES | 1995 |
|
RU2141822C1 |
PHARMACEUTICAL COMPOSITION EXHIBITING ANTICONVULSANT AND ANALGETIC ACTIVITY | 1990 |
|
RU2120796C1 |
MEDICINAL RETARD-FORMULATION CONTAINING TRAMADOL SACCHARINATE | 2000 |
|
RU2292877C2 |
Authors
Dates
1999-11-27—Published
1995-06-22—Filed